India's Biological E looking to make 600 mn J&J vaccine shots a year: CEO

Indian pharmaceutical company Biological E Ltd is looking to contract-manufacture roughly 600 million doses of Johnson and Johnson's Covid-19 vaccine candidate annually, Mahima Datla, managing director of the privately-held company said on Wednesday.

  • Published On Feb 10, 2021 at 01:32 PM IST
Read by: 100 Industry Professionals
Reader Image Read by 100 Industry Professionals
Indian pharmaceutical company Biological E Ltd is looking to contract-manufacture roughly 600 million doses of Johnson and Johnson's Covid-19 vaccine candidate annually, Mahima Datla, managing director of the privately-held company said on Wednesday.

"We are targeting 600 million doses for J&J," said Datla. "This will be in addition to our own product for which we are targeting approximately 1 billion doses."
  • Published On Feb 10, 2021 at 01:32 PM IST
Be the first one to comment.
Comment Now

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles
Scan to download App